Miwon Specialty Chemical Co., Ltd. (KRX:268280)
100,100
-1,900 (-1.86%)
Last updated: May 27, 2026, 2:14 PM KST
Miwon Specialty Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 535,531 | 532,123 | 509,267 | 437,673 | 611,650 | 531,343 |
Other Revenue | -0 | - | - | -0 | -0 | - |
| 535,531 | 532,123 | 509,267 | 437,673 | 611,650 | 531,343 | |
Revenue Growth (YoY) | 2.46% | 4.49% | 16.36% | -28.44% | 15.11% | 42.84% |
Cost of Revenue | 419,775 | 419,283 | 406,471 | 383,706 | 480,003 | 395,584 |
Gross Profit | 115,756 | 112,839 | 102,796 | 53,967 | 131,647 | 135,759 |
Selling, General & Admin | 42,125 | 40,728 | 37,752 | 26,296 | 44,574 | 34,511 |
Research & Development | 6,431 | 6,076 | 4,850 | 4,439 | 4,638 | 4,629 |
Amortization of Goodwill & Intangibles | 0.8 | 0.97 | 1.6 | 68 | 228.8 | 228.83 |
Other Operating Expenses | 181.86 | 221.25 | 242.47 | 211.44 | 220.25 | 198.71 |
Operating Expenses | 48,982 | 47,357 | 44,029 | 31,440 | 50,793 | 40,727 |
Operating Income | 66,774 | 65,482 | 58,767 | 22,527 | 80,853 | 95,032 |
Interest Expense | -1,861 | -1,914 | -2,141 | -2,234 | -1,142 | -60.83 |
Interest & Investment Income | 3,936 | 3,794 | 4,171 | 2,372 | 929.68 | 468.7 |
Currency Exchange Gain (Loss) | 7,009 | 2,114 | 10,260 | 3,533 | 3,329 | 9,176 |
Other Non Operating Income (Expenses) | 2,152 | 1,922 | 451.09 | 639.18 | 671.35 | 878.7 |
EBT Excluding Unusual Items | 78,010 | 71,398 | 71,508 | 26,837 | 84,642 | 105,494 |
Gain (Loss) on Sale of Investments | - | - | - | -12.1 | - | - |
Gain (Loss) on Sale of Assets | 990.1 | 962.33 | 461.86 | 187.66 | 254.66 | 4.29 |
Pretax Income | 79,000 | 72,361 | 71,970 | 27,013 | 84,896 | 105,499 |
Income Tax Expense | 12,580 | 11,058 | 17,403 | 8,408 | 20,072 | 25,595 |
Net Income | 66,421 | 61,303 | 54,567 | 18,605 | 64,824 | 79,903 |
Net Income to Common | 66,421 | 61,303 | 54,567 | 18,605 | 64,824 | 79,903 |
Net Income Growth | 16.04% | 12.34% | 193.30% | -71.30% | -18.87% | 130.50% |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change (YoY) | -0.95% | -0.95% | -1.26% | -1.24% | -0.27% | -1.86% |
EPS (Basic) | 13749.50 | 12662.17 | 11163.61 | 3758.22 | 12932.24 | 15897.28 |
EPS (Diluted) | 13749.32 | 12662.00 | 11163.61 | 3758.00 | 12932.00 | 15897.00 |
EPS Growth | 17.15% | 13.42% | 197.06% | -70.94% | -18.65% | 134.85% |
Free Cash Flow | 37,563 | 31,398 | 34,261 | 84,176 | -11,155 | -13,161 |
Free Cash Flow Per Share | 7775.85 | 6485.34 | 7009.32 | 17003.96 | -2225.48 | -2618.39 |
Gross Margin | 21.62% | 21.20% | 20.18% | 12.33% | 21.52% | 25.55% |
Operating Margin | 12.47% | 12.31% | 11.54% | 5.15% | 13.22% | 17.89% |
Profit Margin | 12.40% | 11.52% | 10.71% | 4.25% | 10.60% | 15.04% |
Free Cash Flow Margin | 7.01% | 5.90% | 6.73% | 19.23% | -1.82% | -2.48% |
EBITDA | 91,862 | 91,395 | 85,421 | 50,742 | 101,140 | 111,784 |
EBITDA Margin | 17.15% | 17.18% | 16.77% | 11.59% | 16.54% | 21.04% |
D&A For EBITDA | 25,088 | 25,913 | 26,653 | 28,214 | 20,287 | 16,752 |
EBIT | 66,774 | 65,482 | 58,767 | 22,527 | 80,853 | 95,032 |
EBIT Margin | 12.47% | 12.31% | 11.54% | 5.15% | 13.22% | 17.89% |
Effective Tax Rate | 15.92% | 15.28% | 24.18% | 31.13% | 23.64% | 24.26% |
Advertising Expenses | - | 6.73 | 6.11 | 23.72 | 23.99 | 15.53 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.